Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1987-10-01
1990-12-11
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530317, 530323, 530328, 530329, 530330, 530331, 530332, 514 11, 514400, 514 18, 514 15, 514 16, 514 17, 564153, 540482, 540483, 540467, 540470, 540604, 540608, 540544, 540553, 540575, 546245, 546215, 546221, 546226, 546242, 544 54, 544 584, 544 88, 544 97, 544163, 544168, 544316, 544319, 544334, 544335, 544384, 544389, 548531, 548215, 548188, 548201, 548228, 548230, 548300, 548320, 548952, 548953, 548951, 2609982, A61K 3702, A61K 3700, A61K 31415, C07K 500
Patent
active
049771418
ABSTRACT:
Non-peptidyl compounds characterized generally as aminoacyl aminodiol carbamates are useful as renin inhibitors for the treatment of hypertension.
REFERENCES:
patent: 4743585 (1988-05-01), Hudspeth et al.
Tsuruo, et al., Japanese Journal Cancer Research, 77, 682-692, Jul. 1986.
Shinoda, et al., Cancer Research, 49, 1722-1726, Apr. 1, 1989.
Burger, Medicinal Chemistry, Interscience Pub., Inc., New York, (1960), pp. 565-571, 579-581, & 600-601.
Matsushita et al, J. Antibiotics 28 1016-1018 (1975).
Lazar et al, Biochem. Pharma. 23 1776-2778 (1974).
Miller et al, Biochem. Pharma. 21 2941-2944 (1972).
Haber, Clinical Sciences 59 7s-19s (1980).
Rich et al, J. Org. Chem. 43 3624 (1978).
Rich et al, J. Med. Chem. 23 27 (1980).
Haber, Clin. and Exper. Hyper. A5(7 & 8) 1193 (1983).
Umezawa et al., J. Antibiot. (Tokyo) 23:259-262 (1970).
Gross et al., Science 175: 656 (1971).
Boger et al., Nature 303 81 (1983).
Kokubu et al., Biochem. Biophys. Res. Commun. 118 929 (1984).
Castro et al, FEBS Lett. 167 273 (1984).
Hanson et al., Biochem. Biophys. Res. Comm. 132 155-161 (1985).
Hanson et al., Biochem. Biophys. Res. Comm. 146 959-963 (1985).
Marshall, Federation Proc. 35 2494-2501 (1976).
Burton et al., Proc. Natl. Acad. Sci. USA 77 5476-5479 (1980).
Suketa et al., Biochemistry 14 3188 (1975).
Swales, Pharm. Ther. 7 173-201 (1979).
Kokubu et al., Nature 217 456-457 (1968).
Baran John S.
Hanson Gunnar J.
Ford John M.
G. D. Searle & Co.
Keane J. Timothy
Matukaitis Paul D.
Whittenbaugh Robert C.
LandOfFree
Peptidyl .alpha.-aminoacyl aminodiol carbamates as anti-hyperten does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptidyl .alpha.-aminoacyl aminodiol carbamates as anti-hyperten, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptidyl .alpha.-aminoacyl aminodiol carbamates as anti-hyperten will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-390311